Vendor Neutral Archive (VNA) & PACS Market by Product Type (Department, Multi-department, Multi-Site), Modality (CT, MRI, X-rays, Ultrasound, Mammo, PET), Application (Cardio, Onco, Neuro), End User (Hospital, ASC, Diag center) & Region - Global Forecast to 2029

May 2024 | 407 pages | ID: V37E851464FEN
MarketsandMarkets

Abstracts

The global Vendor Neutral Archive ( VNA ) & PACS market is projected to reach USD 7.3 billion by 2029 from USD 4.6 billion in 2024, at a CAGR of 9.5% from 2024 to 2029. The growth of the market is fuelled by rapid digitization of healthcare records and medical imaging data, regulatory compliance requirements, and growing need for data storage and management solutions. However, integration with existing healthcare IT system, data security and privacy concerns poses a significant challenge within this market.

“Vendor Neutral Archive ( VNA ) & PACS, multi-site VNA segment to witness the highest growth during the forecast period.”

Based on product type, the Vendor Neutral Archive ( VNA ) & PACS market is segmented into VNA and PACS. The VNA segment held the largest market share in 2023. The VNA segment encompasses of department VNA, multi-department VNA and multi-site VNA. The multi-site VNA segment to witness the highest growth during forecast period. One major factor contributing to the growth of this segment is the increasing demand for seamless data accessibility and interoperability within healthcare systems. As healthcare organizations strive to streamline their operations and improve patient care, they are increasingly turning VNAs to consolidate medical imaging data from multiple sites and disparate systems into a single, centralized repository. This enables healthcare providers to access patient information efficiently, regardless of location, leading to enhanced diagnostic accuracy and treatment planning. Moreover, the COVID-19 pandemic has accelerated the adoption of telemedicine and remote patient monitoring, further driving the demand for multi-site VNAs. With healthcare providers increasingly relying on remote access to medical imaging data for virtual consultations and remote diagnostics, the need for a centralized, secure, and interoperable storage solution has become more distinct ultimately driving the growth of this segment throughout the forecast period.

“On-premise model held the largest market share in the Vendor Neutral Archive ( VNA ) & PACS Market .”

Based on deployment, the Vendor Neutral Archive ( VNA ) & PACS market is segmented into on-premise and cloud based model. The on-premise mode of deployment held the largest market share in 2023. As the cost structure associated with on-premise solutions are used by several healthcare organizations, especially those with budget constraints or a preference for capital expenditures over operational expenses. Furthermore, the total cost of ownership (TCO) remains a significant consideration for healthcare organizations when choosing between deployment models. While cloud-based VNAs offer advantages such as lower upfront costs and scalability, on-premises deployments can be more cost-effective over the long term, especially for organizations with predictable storage needs and established IT infrastructures. With advancements in storage technologies and more efficient hardware options, on-premises VNAs can deliver high performance and reliability at a lower TCO compared to cloud-based alternatives. However, cloud-based model will grow at the fastest CAGR in the forecast period.

“ Hospital & Clinics segment to register the highest growth in the Vendor Neutral Archive ( VNA ) & PACS market during the forecast period.”

Based on end user, the Vendor Neutral Archive ( VNA ) & PACS solution market is segmented into hospitals and clinics, ambulatory surgical centers, long-term care facilities, nursing centers and other end-users which includes maternity care centers, trauma & emergency care centers. In 2023, the hospital & clinics segment held the largest share among the end users. As these end-user are witnessing a growing volume of medical imaging data generated from various diagnostic modalities such as X-rays, MRIs, CT scans, and ultrasounds. This surge in imaging data is driven by factors such as an aging population, increasing prevalence of chronic diseases, and advancements in medical imaging technology. As hospitals and clinics continue to prioritize efficiency, collaboration, and compliance, VNA and PACS solutions will play a crucial role in transforming healthcare delivery and enhancing patient outcomes.

“APAC is estimated to register the highest CAGR during the forecast period.”

In this report, the Vendor Neutral Archive ( VNA ) & PACS market is segmented segments, namely, North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The Vendor Neutral Archive ( VNA ) & PACS market in APAC is projected to register the highest CAGR rate during the forecast period. The growth of this region is due to rising medical imaging investments, and technological advancements in diagnostic imaging modalities. Moreover, advancements in technology and the growing prevalence of cloud computing are making VNA and PACS more accessible and affordable in APAC region. As healthcare providers in APAC continue to prioritize efficiency, accessibility, and quality of care, VNA and PACS solutions will play a pivotal role in driving healthcare transformation and improving patient outcomes across the region.

Breakdown of supply-side primary interviews, by company type, designation, and region:

• By Company Type: Tier 1 (40%), Tier 2 (35%), and Tier 3 (25%)
• By Designation: C-level (35%), Director-level (45%), and Others (20%)
• By Region: North America (55%), Europe (20%), Asia Pacific (15%), Latin America (5%) and Middle East Africa (5%)

List of Companies Profiled in the Report

• Hyland Software, Inc. (US)
• Agfa-Gevaert Group. (Belgium)
• Intelerad Medical Systems Inc (Canada)
• CANON MEDICAL SYSTEMS CORPORATION (Japan)
• FUJIFILM Holdings Corporation (Japan)
• GE HEALTHCARE TECHNOLOGIES INC. (US),
• Merative (US)
• Sectra AB (Sweden)
• Siemens Healthcare Limited (Germany)
• BridgeHead Software Ltd. (UK)
• Canopy Partners. (US)
• Novarad Corporation.(US)
• POSTDICOM (Netherlands)
• AdvaHealth Solutions Pte Ltd (Singapore)
• CrelioHealth (India)
• Medicasoft. (US)
• Esaote SPA (Italy)
• PaxeraHealth (US)
• VISUS Health IT GmbH (Germany)
• S (US), Dedalus S.p.A. (Italy)
• SoftTeam Solutions Pvt Ltd. (India)
• ARO Systems (Australia)
• Central Data Networks (Australia)
• ONEPACS (US)

Research Coverage

This report studies the Vendor Neutral Archive ( VNA ) & PACS market based on product type, modality, deployment, vendor type, application, end user, and region. The report also analyses factors (such as drivers, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total Vendor Neutral Archive ( VNA ) & PACS market. The report forecasts the revenue of the market segments with respect to five major regions.

Reasons to Buy the Report

This report also includes.

• Analysis of key drivers (growing volume of medical Imaging data, shift towards value-based care and digital transformation, healthcare IT-specific government regulations), restrains (rising incidences of data breaches, interoperability challenges), challenges (lack of standardization, user adoption and training), opportunities (patient-centric approach to deliver enhanced care to open new avenues for development of VNAs, cloud-based solutions to represent high-growth opportunites) are contributing the growth of the Vendor Neutral Archive ( VNA ) & PACS market.
• Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the Vendor Neutral Archive ( VNA ) & PACS market.
• Market Development: Comprehensive information on the lucrative emerging markets, components, application, end-user, and region.
• Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, investments in the Vendor Neutral Archive ( VNA ) & PACS market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Vendor Neutral Archive ( VNA ) & PACS Market.

Contents

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
  1.2.1 INCLUSIONS & EXCLUSIONS
1.3 STUDY SCOPE
  1.3.1 MARKET SEGMENTATION
  1.3.2 REGIONS COVERED
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 RECESSION IMPACT

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
  2.1.1 SECONDARY DATA
    2.1.1.1 Key data from secondary sources
  2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
    2.1.2.1 Key data from primary sources
    2.1.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY DEMAND SIDE, SUPPLY SIDE, DESIGNATION, AND REGION
2.2 RESEARCH METHODOLOGY DESIGN
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.3 MARKET SIZE ESTIMATION
FIGURE 5 SUPPLY-SIDE MARKET ESTIMATION: REVENUE SHARE ANALYSIS
  2.3.1 BOTTOM-UP APPROACH
FIGURE 6 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: BOTTOM-UP APPROACH
  2.3.2 TOP-DOWN APPROACH
FIGURE 7 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: TOP-DOWN APPROACH
  2.3.3 TOP-DOWN APPROACH FOR PARENT MARKET ASSESSMENT
  2.3.4 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
TABLE 1 FACTOR ANALYSIS
FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
  2.5.1 OVERALL STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 RESEARCH LIMITATIONS
  2.7.1 METHODOLOGY-RELATED LIMITATIONS
  2.7.2 SCOPE-RELATED LIMITATIONS
2.8 RECESSION IMPACT ANALYSIS
TABLE 2 GLOBAL INFLATION RATE PROJECTION, 2021 2027 (% GROWTH)
TABLE 3 US HEALTH EXPENDITURE, 2019 2022 (USD MILLION)
TABLE 4 US HEALTH EXPENDITURE, 2023 2027 (USD MILLION)

3 EXECUTIVE SUMMARY

FIGURE 11 VNA SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 12 CT SEGMENT TO ACCOUNT FOR LARGEST SHARE BY 2029
FIGURE 13 CLOUD-BASED MODEL SEGMENT TO ACCOUNT FOR LARGEST MARKET BY 2029
FIGURE 14 INDEPENDENT VENDOR SEGMENT TO ACCOUNT FOR LARGER SHARE BY 2029
FIGURE 15 CARDIOLOGY SEGMENT TO ACCOUNT FOR LARGEST MARKET BY 2029
FIGURE 16 HOSPITALS & CLINICS SEGMENT TO LEAD MARKET IN 2024
FIGURE 17 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS

4.1 OVERVIEW OF VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
FIGURE 18 INCREASING VOLUME OF MEDICAL IMAGING DATA TO DRIVE MARKET
4.2 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE AND COUNTRY
FIGURE 19 VNA SEGMENT AND JAPAN TO ACCOUNT FOR SIGNIFICANT SHARE IN 2024
4.3 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 20 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.4 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: REGIONAL MIX
FIGURE 21 NORTH AMERICA TO LEAD MARKET DURING FORECAST PERIOD
4.5 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: DEVELOPED VS. EMERGING MARKETS
FIGURE 22 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 23 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  5.2.1 DRIVERS
    5.2.1.1 Heightened investments in medical imaging technologies
    5.2.1.2 Growing demand for streamlined healthcare data management solutions
    5.2.1.3 Integration of PACS/VNA with Electronic Medical Records (EMRs)
  5.2.2 RESTRAINTS
    5.2.2.1 High initial investment
    5.2.2.2 Lack of standardized protocols and interoperability frameworks
  5.2.3 OPPORTUNITIES
    5.2.3.1 Government initiatives to increase penetration of Al in medical imaging
    5.2.3.2 Increasing medical imaging procedures and large imaging data silos
    5.2.3.3 Rapid uptake of big data in healthcare
  5.2.4 CHALLENGES
    5.2.4.1 Rising security concerns related to cloud-based image processing and analytics
    5.2.4.2 Data security issues

6 INDUSTRY TRENDS

6.1 CURRENT TRENDS
  6.1.1 CLOUD ADOPTION
  6.1.2 AI INTEGRATION
  6.1.3 VALUE-BASED CARE FOCUS
6.2 TECHNOLOGY ANALYSIS
  6.2.1 KEY TECHNOLOGIES
    6.2.1.1 DICOM (Digital Imaging and Communications in Medicine)
    6.2.1.2 Enterprise imaging solutions
    6.2.1.3 Cloud-based storage and services
  6.2.2 COMPLEMENTARY TECHNOLOGIES
    6.2.2.1 Image exchange networks
    6.2.2.2 Data analytics and business intelligence
  6.2.3 ADJACENT TECHNOLOGIES
    6.2.3.1 Health Information Exchange (HIE)
6.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS BUSINESSES
FIGURE 24 REVENUE SHIFT IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
6.4 VALUE CHAIN ANALYSIS
FIGURE 25 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: VALUE CHAIN ANALYSIS
6.5 ECOSYSTEM MAPPING
FIGURE 26 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: ECOSYSTEM MAPPING
6.6 PORTER S FIVE FORCES ANALYSIS
TABLE 5 IMPACT OF PORTER S FIVE FORCES ON VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
  6.6.1 INTENSITY OF COMPETITIVE RIVALRY
  6.6.2 BARGAINING POWER OF SUPPLIERS
  6.6.3 BARGAINING POWER OF BUYERS
  6.6.4 THREAT OF NEW ENTRANTS
  6.6.5 THREAT OF SUBSTITUTES
6.7 KEY CONFERENCES & EVENTS
TABLE 6 LIST OF CONFERENCES & EVENTS, 2024 2025
6.8 PRICING ANALYSIS
  6.8.1 AVERAGE SELLING PRICE (ASP) TREND OF VNA AND PACS SOLUTIONS, BY PRODUCT TYPE
TABLE 7 AVERAGE SELLING PRICE OF VNA AND PACS SOLUTIONS, BY PRODUCT TYPE
  6.8.2 AVERAGE SELLING PRICE TREND, BY REGION
6.9 REGULATORY LANDSCAPE
  6.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  6.9.2 REGULATIONS
    6.9.2.1 US
    6.9.2.2 Europe
    6.9.2.3 China
    6.9.2.4 Japan
    6.9.2.5 India
6.10 PATENT ANALYSIS
  6.10.1 PATENT PUBLICATION TRENDS FOR VNA AND PACS
FIGURE 27 GLOBAL PATENT PUBLICATION TRENDS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, 2015 2024
  6.10.2 JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 28 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR VNA AND PACS (JANUARY 2015 TO APRIL 2024)
6.11 CASE STUDY ANALYSIS
  6.11.1 AMBRA HEALTH UTILIZED AWS CLOUD SERVICES TO PROPEL WORLDWIDE GROWTH OF ITS MEDICAL IMAGING PLATFORM
  6.11.2 NHS TRUST ADOPTED INTEGRATION AND INSTANT DATA ACCESS OFFERED BY SYNAPPS VNA TO ESTABLISH UNIFIED PLATFORM FOR STORING AND MANAGING DICOM IMAGE DATA
6.12 KEY STAKEHOLDERS AND BUYING CRITERIA
  6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP END USERS
TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP END USERS
  6.12.2 BUYING CRITERIA
FIGURE 30 KEY BUYING CRITERIA FOR TOP END USERS
TABLE 13 KEY BUYING CRITERIA FOR TOP THREE END USERS
6.13 END-USER ANALYSIS
  6.13.1 UNMET NEEDS
TABLE 14 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: UNMET NEEDS
  6.13.2 END-USER EXPECTATIONS
TABLE 15 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: END-USER EXPECTATIONS
6.14 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: BUSINESS MODELS
  6.14.1 ENTERPRISE LICENSING:
  6.14.2 SOFTWARE-AS-A-SERVICE (SAAS):
  6.14.3 PAY-PER-USE:
  6.14.4 HYBRID MODELS:

7 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY

7.1 INTRODUCTION
TABLE 16 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018 2022 (USD MILLION)
TABLE 17 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023 2029 (USD MILLION)
7.2 CT
  7.2.1 RAPID RISE IN NEED FOR CT EXAMINATIONS TO SUPPORT MARKET GROWTH
TABLE 18 CT: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 19 CT: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
7.3 MAMMOGRAPHY
  7.3.1 RISE IN NUMBER OF MAMMOGRAPHY PROCEDURES TO DRIVE MARKET GROWTH
TABLE 20 MAMMOGRAPHY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 21 MAMMOGRAPHY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
7.4 ULTRASOUND
  7.4.1 RISING TECHNOLOGICAL ADVANCEMENT IN ULTRASOUND DEVICES TO SUPPORT MARKET GROWTH
TABLE 22 ULTRASOUND: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 23 ULTRASOUND: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
7.5 MAGNETIC RESONANCE IMAGING (MRI)
  7.5.1 MRI IS COST-EFFECTIVE AND EASILY AVAILABLE COMPARED TO PET
TABLE 24 MRI: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 25 MRI: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
7.6 X-RAY
  7.6.1 RAPID ADOPTION OF X-RAY IMAGING COMPARED TO OTHER MODALITIES TO BOOST MARKET
TABLE 26 X-RAY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 27 X-RAY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
7.7 PET
  7.7.1 INCREASING USE OF NUCLEAR MEDICINES TO SUPPORT POPULARITY OF PET
TABLE 28 PET: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 29 PET: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)

8 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL

8.1 INTRODUCTION
TABLE 30 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018 2022 (USD MILLION)
TABLE 31 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023 2029 (USD MILLION)
8.2 ON-PREMISES MODEL
  8.2.1 ON-PREMISES DEPLOYMENT MODEL PROVIDES HEALTHCARE ORGANIZATIONS WITH GREAT CONTROL AND SECURITY OVER SENSITIVE PATIENT DATA
TABLE 32 ON-PREMISES MODEL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 33 ON-PREMISES MODEL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
8.3 CLOUD-BASED MODEL
  8.3.1 TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTIC IMAGING MODALITIES TO DRIVE CLOUD-BASED MODEL S POPULARITY
TABLE 34 CLOUD-BASED MODEL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 35 CLOUD-BASED MODEL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
8.4 HYBRID MODEL
  8.4.1 UNIFIED EFFICIENCY FOR OPTIMAL PERFORMANCE TO DRIVE HYBRID VNA AND PACS SOLUTIONS
TABLE 36 HYBRID MODEL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 37 HYBRID MODEL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)

9 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE

9.1 INTRODUCTION
TABLE 38 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 39 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023 2029 (USD MILLION)
9.2 VNA
TABLE 40 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 41 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 42 VENDOR NEUTRAL ARCHIVE (VNA) MARKET & PACS MARKET FOR VNA PRODUCT TYPES, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 43 VENDOR NEUTRAL ARCHIVE (VNA) MARKET & PACS MARKET FOR VNA PRODUCT TYPES, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
  9.2.1 DEPARTMENT VNA
    9.2.1.1 Limitations in addressing scalability and interoperability challenges across diverse departments to hinder market growth
TABLE 44 DEPARTMENT VNA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 45 DEPARTMENT VNA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
  9.2.2 MULTI-DEPARTMENT VNA
    9.2.2.1 Trend toward adopting value-based platform solutions to support market growth
TABLE 46 MULTI-DEPARTMENT VNA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 47 MULTI-DEPARTMENT VNA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
  9.2.3 MULTI-SITE VNA
    9.2.3.1 Need for storage of large medical image data and seamless sharing within and between enterprises to support market growth
TABLE 48 MULTI-SITE VNA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 49 MULTI-SITE VNA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
9.3 PACS
TABLE 50 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 51 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 52 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR PACS PRODUCT TYPES, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 53 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR PACS PRODUCT TYPES, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
  9.3.1 DEPARTMENT PACS
    9.3.1.1 Increasing storage of medical imaging data across various applications to support market growth
TABLE 54 DEPARTMENT PACS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 55 DEPARTMENT PACS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
  9.3.2 MULTI-DEPARTMENT PACS
    9.3.2.1 Streamlining radiology operations for enhanced image accessibility to support market growth
TABLE 56 MULTI-DEPARTMENT PACS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 57 MULTI-DEPARTMENT PACS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
  9.3.3 MULTI-SITE PACS
    9.3.3.1 Advancement in cloud-based PACS solutions to propel market growth
TABLE 58 MULTI-SITE PACS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 59 MULTI-SITE PACS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)

10 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE

10.1 INTRODUCTION
TABLE 60 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018 2022 (USD MILLION)
TABLE 61 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023 2029 (USD MILLION)
10.2 INDEPENDENT VENDOR
  10.2.1 DOMINANCE OF INDEPENDENT VENDORS TO CAPTURE SIGNIFICANT MARKET SHARE
TABLE 62 INDEPENDENT VENDORS OPERATING IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
TABLE 63 INDEPENDENT VENDOR: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 64 INDEPENDENT VENDOR: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
10.3 THIRD-PARTY VENDOR
  10.3.1 NEED FOR INNOVATIVE SOLUTIONS TO FUEL SURGE IN THIRD-PARTY VENDORS PRESENCE IN MARKET
TABLE 65 THIRD-PARTY VENDORS OPERATING IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
TABLE 66 THIRD-PARTY VENDOR: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 67 THIRD-PARTY VENDOR: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)

11 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION

11.1 INTRODUCTION
TABLE 68 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018 2022 (USD MILLION)
TABLE 69 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023 2029 (USD MILLION)
11.2 CARDIOLOGY
  11.2.1 RISING CASES OF CARDIAC DISORDERS TO DRIVE MARKET
TABLE 70 CARDIOLOGY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 71 CARDIOLOGY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
11.3 ORTHOPEDIC
  11.3.1 GROWTH IN CASES OF ARTHRITIS TO SUPPORT MARKET GROWTH
TABLE 72 ORTHOPEDIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 73 ORTHOPEDIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
11.4 ONCOLOGY
  11.4.1 RISE IN NUMBER OF CANCER CASES TO DRIVE USE OF VNA AND PACS SOLUTIONS FOR ONCOLOGY
TABLE 74 ONCOLOGY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 75 ONCOLOGY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
11.5 NEUROLOGY
  11.5.1 INCREASING DEMAND FOR ADVANCED NEUROLOGICAL IMAGING TECHNOLOGIES TO SPUR GROWTH
TABLE 76 NEUROLOGY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 77 NEUROLOGY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
11.6 OBSTETRICS & GYNECOLOGY
  11.6.1 USE OF 3D AND 4D IMAGING FOR MONITORING FETUS GROWTH AND DIAGNOSING HIGH-RISK PREGNANCIES TO DRIVE APPLICATION OF VNA AND PACS SOLUTIONS
TABLE 78 OBSTETRICS & GYNECOLOGY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 79 OBSTETRICS & GYNECOLOGY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
11.7 OTHER APPLICATIONS
TABLE 80 OTHER APPLICATIONS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 81 OTHER APPLICATIONS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)

12 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER

12.1 INTRODUCTION
TABLE 82 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018 2022 (USD MILLION)
TABLE 83 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023 2029 (USD MILLION)
12.2 HOSPITALS & CLINICS
  12.2.1 GROWING NEED TO IMPROVE PROFITABILITY OF HEALTHCARE SERVICES TO DRIVE USE OF HCIT IN HOSPITALS
TABLE 84 HOSPITALS & CLINICS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 85 HOSPITALS & CLINICS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
12.3 DIAGNOSTIC CENTERS
  12.3.1 POPULARITY OF DIAGNOSTIC CENTERS TO PROPEL USE OF VNA AND PACS SOLUTIONS
TABLE 86 DIAGNOSTIC CENTERS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 87 DIAGNOSTIC CENTERS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
12.4 AMBULATORY SURGERY CENTERS
  12.4.1 INCREASING NUMBER OF INTERVENTIONAL IMAGING PROCEDURES TO SUPPORT USE OF VNA AND PACS SOLUTIONS IN AMBULATORY SURGERY CENTERS
TABLE 88 AMBULATORY SURGERY CENTERS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 89 AMBULATORY SURGERY CENTERS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
12.5 OTHER END USERS
TABLE 90 OTHER END USERS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 91 OTHER END USERS: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)

13 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY REGION

13.1 INTRODUCTION
TABLE 92 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY REGION, 2018 2022 (USD MILLION)
TABLE 93 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY REGION, 2023 2029 (USD MILLION)
13.2 NORTH AMERICA
FIGURE 31 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET SNAPSHOT
TABLE 94 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 95 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
TABLE 96 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 97 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 98 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 99 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 100 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 101 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 102 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018 2022 (USD MILLION)
TABLE 103 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023 2029 (USD MILLION)
TABLE 104 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018 2022 (USD MILLION)
TABLE 105 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023 2029 (USD MILLION)
TABLE 106 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018 2022 (USD MILLION)
TABLE 107 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023 2029 (USD MILLION)
TABLE 108 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018 2022 (USD MILLION)
TABLE 109 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023 2029 (USD MILLION)
TABLE 110 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018 2022 (USD MILLION)
TABLE 111 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023 2029 (USD MILLION)
  13.2.1 NORTH AMERICA: RECESSION IMPACT
  13.2.2 US
    13.2.2.1 Rising incidences of chronic diseases to drive market
TABLE 112 US: KEY MACRO INDICATORS
TABLE 113 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 114 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 115 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 116 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE MARKET, 2023 2029 (USD MILLION)
TABLE 117 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 118 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE MARKET, 2023 2029 (USD MILLION)
TABLE 119 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018 2022 (USD MILLION)
TABLE 120 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023 2029 (USD MILLION)
TABLE 121 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018 2022 (USD MILLION)
TABLE 122 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023 2029 (USD MILLION)
TABLE 123 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018 2022 (USD MILLION)
TABLE 124 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023 2029 (USD MILLION)
TABLE 125 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018 2022 (USD MILLION)
TABLE 126 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023 2029 (USD MILLION)
TABLE 127 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018 2022 (USD MILLION)
TABLE 128 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023 2029 (USD MILLION)
  13.2.3 CANADA
    13.2.3.1 Rising cases of end-stage kidney diseases to propel use of VNA and PACS solutions
TABLE 129 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 130 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 131 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 132 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 133 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 134 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 135 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018 2022 (USD MILLION)
TABLE 136 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023 2029 (USD MILLION)
TABLE 137 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018 2022 (USD MILLION)
TABLE 138 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023 2029 (USD MILLION)
TABLE 139 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018 2022 (USD MILLION)
TABLE 140 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023 2029 (USD MILLION)
TABLE 141 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018 2022 (USD MILLION)
TABLE 142 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023 2029 (USD MILLION)
TABLE 143 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018 2022 (USD MILLION)
TABLE 144 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023 2029 (USD MILLION)
13.3 EUROPE
  13.3.1 EUROPE: RECESSION IMPACT
TABLE 145 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 146 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
TABLE 147 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 148 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 149 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 150 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE MARKET, 2023 2029 (USD MILLION)
TABLE 151 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 152 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE MARKET, 2023 2029 (USD MILLION)
TABLE 153 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018 2022 (USD MILLION)
TABLE 154 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023 2029 (USD MILLION)
TABLE 155 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018 2022 (USD MILLION)
TABLE 156 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023 2029 (USD MILLION)
TABLE 157 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018 2022 (USD MILLION)
TABLE 158 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023 2029 (USD MILLION)
TABLE 159 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018 2022 (USD MILLION)
TABLE 160 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023 2029 (USD MILLION)
TABLE 161 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018 2022 (USD MILLION)
TABLE 162 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023 2029 (USD MILLION)
  13.3.2 GERMANY
    13.3.2.1 High number of MRI units to drive market
TABLE 163 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 164 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 165 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 166 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 167 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 168 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 169 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018 2022 (USD MILLION)
TABLE 170 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023 2029 (USD MILLION)
TABLE 171 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018 2022 (USD MILLION)
TABLE 172 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023 2029 (USD MILLION)
TABLE 173 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018 2022 (USD MILLION)
TABLE 174 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023 2029 (USD MILLION)
TABLE 175 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018 2022 (USD MILLION)
TABLE 176 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023 2029 (USD MILLION)
TABLE 177 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018 2022 (USD MILLION)
TABLE 178 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023 2029 (USD MILLION)
  13.3.3 UK
    13.3.3.1 Increasing investments in diagnostic imaging to drive market
FIGURE 32 COUNT OF DIAGNOSTIC IMAGING ACTIVITY IN UK, ON NHS PATIENTS, FROM JANUARY 2022 TO JANUARY 2023
TABLE 179 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 180 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 181 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 182 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE 2023 2029 (USD MILLION)
TABLE 183 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 184 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 185 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018 2022 (USD MILLION)
TABLE 186 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023 2029 (USD MILLION)
TABLE 187 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018 2022 (USD MILLION)
TABLE 188 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023 2029 (USD MILLION)
TABLE 189 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018 2022 (USD MILLION)
TABLE 190 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023 2029 (USD MILLION)
TABLE 191 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018 2022 (USD MILLION)
TABLE 192 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023 2029 (USD MILLION)
TABLE 193 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018 2022 (USD MILLION)
TABLE 194 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023 2029 (USD MILLION)
  13.3.4 FRANCE
    13.3.4.1 Rising target patient population and government-funded investments for advanced medical equipment to fuel uptake
TABLE 195 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 196 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 197 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 198 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 199 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 200 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE MARKET, 2023 2029 (USD MILLION)
TABLE 201 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018 2022 (USD MILLION)
TABLE 202 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023 2029 (USD MILLION)
TABLE 203 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018 2022 (USD MILLION)
TABLE 204 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023 2029 (USD MILLION)
TABLE 205 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018 2022 (USD MILLION)
TABLE 206 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023 2029 (USD MILLION)
TABLE 207 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018 2022 (USD MILLION)
TABLE 208 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023 2029 (USD MILLION)
TABLE 209 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018 2022 (USD MILLION)
TABLE 210 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023 2029 (USD MILLION)
  13.3.5 ITALY
    13.3.5.1 Established healthcare infrastructure to support overall market growth
TABLE 211 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 212 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 213 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 214 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 215 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 216 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 217 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018 2022 (USD MILLION)
TABLE 218 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023 2029 (USD MILLION)
TABLE 219 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018 2022 (USD MILLION)
TABLE 220 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023 2029 (USD MILLION)
TABLE 221 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018 2022 (USD MILLION)
TABLE 222 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023 2029 (USD MILLION)
TABLE 223 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018 2022 (USD MILLION)
TABLE 224 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023 2029 (USD MILLION)
TABLE 225 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018 2022 (USD MILLION)
TABLE 226 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023 2029 (USD MILLION)
  13.3.6 SPAIN
    13.3.6.1 Growing access to advanced cancer diagnostics to propel market
TABLE 227 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 228 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 229 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 230 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 231 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 232 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 233 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018 2022 (USD MILLION)
TABLE 234 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023 2029 (USD MILLION)
TABLE 235 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018 2022 (USD MILLION)
TABLE 236 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023 2029 (USD MILLION)
TABLE 237 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018 2022 (USD MILLION)
TABLE 238 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023 2029 (USD MILLION)
TABLE 239 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018 2022 (USD MILLION)
TABLE 240 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023 2029 (USD MILLION)
TABLE 241 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018 2022 (USD MILLION)
TABLE 242 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023 2029 (USD MILLION)
  13.3.7 REST OF EUROPE
TABLE 243 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 244 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 245 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 246 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE MARKET, 2023 2029 (USD MILLION)
TABLE 247 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 248 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE MARKET, 2023 2029 (USD MILLION)
TABLE 249 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018 2022 (USD MILLION)
TABLE 250 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023 2029 (USD MILLION)
TABLE 251 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018 2022 (USD MILLION)
TABLE 252 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023 2029 (USD MILLION)
TABLE 253 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018 2022 (USD MILLION)
TABLE 254 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023 2029 (USD MILLION)
TABLE 255 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018 2022 (USD MILLION)
TABLE 256 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023 2029 (USD MILLION)
TABLE 257 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018 2022 (USD MILLION)
TABLE 258 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023 2029 (USD MILLION)
13.4 ASIA PACIFIC
  13.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 33 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET SNAPSHOT
TABLE 259 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 260 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
TABLE 261 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 262 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 263 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 264 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 265 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 266 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 267 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018 2022 (USD MILLION)
TABLE 268 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023 2029 (USD MILLION)
TABLE 269 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018 2022 (USD MILLION)
TABLE 270 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023 2029 (USD MILLION)
TABLE 271 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018 2022 (USD MILLION)
TABLE 272 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023 2029 (USD MILLION)
TABLE 273 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018 2022 (USD MILLION)
TABLE 274 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023 2029 (USD MILLION)
TABLE 275 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018 2022 (USD MILLION)
TABLE 276 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023 2029 (USD MILLION)
  13.4.2 JAPAN
    13.4.2.1 Presence of universal healthcare coverage to fuel market
TABLE 277 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 278 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 279 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 280 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE MARKET, 2023 2029 (USD MILLION)
TABLE 281 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 282 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 283 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018 2022 (USD MILLION)
TABLE 284 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023 2029 (USD MILLION)
TABLE 285 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018 2022 (USD MILLION)
TABLE 286 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023 2029 (USD MILLION)
TABLE 287 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018 2022 (USD MILLION)
TABLE 288 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023 2029 (USD MILLION)
TABLE 289 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018 2022 (USD MILLION)
TABLE 290 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023 2029 (USD MILLION)
TABLE 291 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018 2022 (USD MILLION)
TABLE 292 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023 2029 (USD MILLION)
  13.4.3 CHINA
    13.4.3.1 Strong government support for healthcare reforms and increasing number of medical imaging procedures to drive market
TABLE 293 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 294 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 295 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 296 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE MARKET, 2023 2029 (USD MILLION)
TABLE 297 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 298 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 299 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018 2022 (USD MILLION)
TABLE 300 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023 2029 (USD MILLION)
TABLE 301 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018 2022 (USD MILLION)
TABLE 302 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023 2029 (USD MILLION)
TABLE 303 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018 2022 (USD MILLION)
TABLE 304 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023 2029 (USD MILLION)
TABLE 305 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018 2022 (USD MILLION)
TABLE 306 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023 2029 (USD MILLION)
TABLE 307 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018 2022 (USD MILLION)
TABLE 308 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023 2029 (USD MILLION)
  13.4.4 INDIA
    13.4.4.1 Improving healthcare infrastructure to support growth of medical image analysis software market
TABLE 309 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 310 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 311 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 312 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 313 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 314 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 315 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018 2022 (USD MILLION)
TABLE 316 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023 2029 (USD MILLION)
TABLE 317 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018 2022 (USD MILLION)
TABLE 318 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023 2029 (USD MILLION)
TABLE 319 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018 2022 (USD MILLION)
TABLE 320 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023 2029 (USD MILLION)
TABLE 321 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018 2022 (USD MILLION)
TABLE 322 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023 2029 (USD MILLION)
TABLE 323 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018 2022 (USD MILLION)
TABLE 324 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023 2029 (USD MILLION)
  13.4.5 REST OF ASIA PACIFIC
TABLE 325 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 326 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 327 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 328 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 329 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 330 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE MARKET, 2023 2029 (USD MILLION)
TABLE 331 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018 2022 (USD MILLION)
TABLE 332 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023 2029 (USD MILLION)
TABLE 333 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018 2022 (USD MILLION)
TABLE 334 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023 2029 (USD MILLION)
TABLE 335 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018 2022 (USD MILLION)
TABLE 336 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023 2029 (USD MILLION)
TABLE 337 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018 2022 (USD MILLION)
TABLE 338 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023 2029 (USD MILLION)
TABLE 339 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018 2022 (USD MILLION)
TABLE 340 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023 2029 (USD MILLION)
13.5 LATIN AMERICA
  13.5.1 LATIN AMERICA: RECESSION IMPACT
TABLE 341 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2018 2022 (USD MILLION)
TABLE 342 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2023 2029 (USD MILLION)
TABLE 343 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 344 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 345 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 346 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 347 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 348 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 349 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018 2022 (USD MILLION)
TABLE 350 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023 2029 (USD MILLION)
TABLE 351 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018 2022 (USD MILLION)
TABLE 352 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023 2029 (USD MILLION)
TABLE 353 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018 2022 (USD MILLION)
TABLE 354 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023 2029 (USD MILLION)
TABLE 355 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018 2022 (USD MILLION)
TABLE 356 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023 2029 (USD MILLION)
TABLE 357 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018 2022 (USD MILLION)
TABLE 358 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023 2029 (USD MILLION)
  13.5.2 BRAZIL
    13.5.2.1 High export of medical devices to propel market
TABLE 359 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 360 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 361 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 362 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 363 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 364 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE MARKET, 2023 2029 (USD MILLION)
TABLE 365 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018 2022 (USD MILLION)
TABLE 366 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023 2029 (USD MILLION)
TABLE 367 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018 2022 (USD MILLION)
TABLE 368 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023 2029 (USD MILLION)
TABLE 369 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018 2022 (USD MILLION)
TABLE 370 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023 2029 (USD MILLION)
TABLE 371 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018 2022 (USD MILLION)
TABLE 372 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023 2029 (USD MILLION)
TABLE 373 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018 2022 (USD MILLION)
TABLE 374 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023 2029 (USD MILLION)
  13.5.3 MEXICO
    13.5.3.1 Rapid technological advancements in imaging solutions to support market growth
TABLE 375 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 376 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 377 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 378 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 379 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 380 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 381 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018 2022 (USD MILLION)
TABLE 382 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023 2029 (USD MILLION)
TABLE 383 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018 2022 (USD MILLION)
TABLE 384 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023 2029 (USD MILLION)
TABLE 385 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018 2022 (USD MILLION)
TABLE 386 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023 2029 (USD MILLION)
TABLE 387 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018 2022 (USD MILLION)
TABLE 388 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023 2029 (USD MILLION)
TABLE 389 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018 2022 (USD MILLION)
TABLE 390 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023 2029 (USD MILLION)
  13.5.4 REST OF LATIN AMERICA
TABLE 391 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 392 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 393 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 394 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 395 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 396 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 397 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018 2022 (USD MILLION)
TABLE 398 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023 2029 (USD MILLION)
TABLE 399 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018 2022 (USD MILLION)
TABLE 400 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023 2029 (USD MILLION)
TABLE 401 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018 2022 (USD MILLION)
TABLE 402 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023 2029 (USD MILLION)
TABLE 403 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018 2022 (USD MILLION)
TABLE 404 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023 2029 (USD MILLION)
TABLE 405 REST OF LATINA AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018 2022 (USD MILLION)
TABLE 406 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023 2029 (USD MILLION)
13.6 MIDDLE EAST & AFRICA
  13.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT ANALYSIS
TABLE 407 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY REGION, 2018 2022 (USD MILLION)
TABLE 408 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY REGION, 2023 2029 (USD MILLION)
TABLE 409 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 410 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 411 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 412 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 413 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 414 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 415 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018 2022 (USD MILLION)
TABLE 416 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023 2029 (USD MILLION)
TABLE 417 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018 2022 (USD MILLION)
TABLE 418 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023 2029 (USD MILLION)
TABLE 419 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018 2022 (USD MILLION)
TABLE 420 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023 2029 (USD MILLION)
TABLE 421 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018 2022 (USD MILLION)
TABLE 422 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023 2029 (USD MILLION)
TABLE 423 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018 2022 (USD MILLION)
TABLE 424 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023 2029 (USD MILLION)
  13.6.2 GCC COUNTRIES
    13.6.2.1 Technological integration to spur inclusivity, accessibility, affordability, and growth in healthcare sector
TABLE 425 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 426 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 427 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 428 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 429 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 430 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 431 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018 2022 (USD MILLION)
TABLE 432 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023 2029 (USD MILLION)
TABLE 433 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018 2022 (USD MILLION)
TABLE 434 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023 2029 (USD MILLION)
TABLE 435 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018 2022 (USD MILLION)
TABLE 436 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023 2029 (USD MILLION)
TABLE 437 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018 2022 (USD MILLION)
TABLE 438 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023 2029 (USD MILLION)
TABLE 439 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018 2022 (USD MILLION)
TABLE 440 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023 2029 (USD MILLION)
  13.6.3 REST OF MIDDLE EAST & AFRICA
TABLE 441 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 442 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 443 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 444 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VNA PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 445 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2018 2022 (USD MILLION)
TABLE 446 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PACS PRODUCT TYPE, 2023 2029 (USD MILLION)
TABLE 447 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2018 2022 (USD MILLION)
TABLE 448 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2023 2029 (USD MILLION)
TABLE 449 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2018 2022 (USD MILLION)
TABLE 450 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2023 2029 (USD MILLION)
TABLE 451 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2018 2022 (USD MILLION)
TABLE 452 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2023 2029 (USD MILLION)
TABLE 453 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2018 2022 (USD MILLION)
TABLE 454 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2023 2029 (USD MILLION)
TABLE 455 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2018 2022 (USD MILLION)
TABLE 456 REST OF MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2023 2029 (USD MILLION)

14 COMPETITIVE LANDSCAPE

14.1 OVERVIEW
14.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
FIGURE 34 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET
14.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS
FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS
14.4 MARKET SHARE ANALYSIS
FIGURE 36 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: MARKET SHARE ANALYSIS (2022)
TABLE 457 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: DEGREE OF COMPETITION
14.5 BRAND/SOFTWARE COMPARATIVE ANALYSIS
  14.5.1 AGFA-GEVAERT GROUP
  14.5.2 FUJIFILM HOLDINGS CORPORATION
  14.5.3 MERATIVE
  14.5.4 NOVARAD CORPORATION
  14.5.5 PAXERAHEALTH
  14.5.6 ONEPACS
14.6 COMPANY EVALUATION AND FINANCIAL METRICS
FIGURE 37 EV/EBITDA OF KEY VENDORS
FIGURE 38 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF VNA AND PACS VENDORS
14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  14.7.1 STARS
  14.7.2 EMERGING LEADERS
  14.7.3 PERVASIVE PLAYERS
  14.7.4 PARTICIPANTS
FIGURE 39 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  14.7.5 COMPANY FOOTPRINT ANALYSIS
TABLE 458 OVERALL COMPANY FOOTPRINT
TABLE 459 PRODUCT TYPE FOOTPRINT
TABLE 460 DEPLOYMENT FOOTPRINT
TABLE 461 END USER FOOTPRINT
TABLE 462 REGIONAL FOOTPRINT (19 COMPANIES)
14.8 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
  14.8.1 PROGRESSIVE COMPANIES
  14.8.2 RESPONSIVE COMPANIES
  14.8.3 DYNAMIC COMPANIES
  14.8.4 STARTING BLOCKS
FIGURE 40 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
  14.8.5 COMPETITIVE BENCHMARKING
TABLE 463 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: DETAILED LIST OF KEY START-UPS/SMES
TABLE 464 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
14.9 COMPETITIVE SITUATIONS & TRENDS
  14.9.1 PRODUCT LAUNCHES & UPGRADES
TABLE 465 PRODUCT LAUNCHES & UPGRADES, AUGUST 2021 NOVEMBER 2023
  14.9.2 DEALS
TABLE 466 DEALS, JANUARY 2023 MARCH 2024
  14.9.3 OTHER DEVELOPMENTS
TABLE 467 OTHER DEVELOPMENTS, NOVEMBER 2022 NOVEMBER 2024

15 COMPANY PROFILES

15.1 KEY COMPANIES
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
  15.1.1 AGFA-GEVAERT GROUP
TABLE 468 AGFA-GEVAERT GROUP: BUSINESS OVERVIEW
FIGURE 41 AGFA-GEVAERT GROUP: COMPANY SNAPSHOT
TABLE 469 AGFA-GEVAERT GROUP: SOLUTIONS OFFERED
TABLE 470 AGFA-GEVAERT GROUP: DEALS, JANUARY 2020 APRIL 2024
  15.1.2 FUJIFILM HOLDINGS CORPORATION
TABLE 471 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
FIGURE 42 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
TABLE 472 FUJIFILM HOLDINGS CORPORATION: SOLUTIONS OFFERED
TABLE 473 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2020 APRIL 2024
TABLE 474 FUJIFILM HOLDINGS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2020 APRIL 2024
  15.1.3 SECTRA AB
TABLE 475 SECTRA AB: BUSINESS OVERVIEW
FIGURE 43 SECTRA AB: COMPANY SNAPSHOT
TABLE 476 SECTRA AB: SOLUTIONS OFFERED
  15.1.4 GE HEALTHCARE TECHNOLOGIES INC.
TABLE 477 GE HEALTHCARE TECHNOLOGIES INC.: BUSINESS OVERVIEW
FIGURE 44 GE HEALTHCARE TECHNOLOGIES INC.: COMPANY SNAPSHOT
TABLE 478 GE HEALTHCARE TECHNOLOGIES INC.: SOLUTIONS OFFERED
TABLE 479 GE HEALTHCARE TECHNOLOGIES INC.: PRODUCTS LAUNCHES, JANUARY 2020 APRIL 2024
  15.1.5 MERATIVE
TABLE 480 MERATIVE: BUSINESS OVERVIEW
TABLE 481 MERATIVE: SOLUTIONS OFFERED
TABLE 482 MERATIVE: DEALS, NOVEMBER 2023
  15.1.6 KONINKLIJKE PHILIPS N.V.
TABLE 483 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
FIGURE 45 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 484 KONINKLIJKE PHILIPS N.V.: SOLUTIONS OFFERED
TABLE 485 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES, JANUARY 2020 APRIL 2024
TABLE 486 KONINKLIJKE PHILIPS N.V.: DEALS, APRIL 2023
  15.1.7 CANON MEDICAL SYSTEMS CORPORATION
TABLE 487 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
FIGURE 46 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT
TABLE 488 CANON MEDICAL SYSTEMS CORPORATION: SOLUTIONS OFFERED
TABLE 489 CANON MEDICAL SYSTEMS CORPORATION: DEALS, NOVEMBER 203
TABLE 490 CANON MEDICAL SYSTEMS CORPORATION: OTHER DEVELOPMENTS, NOVEMBER 2022
  15.1.8 INTELERAD MEDICAL SYSTEMS INCORPORATED
TABLE 491 INTELERAD MEDICAL SYSTEMS INCORPORATED: BUSINESS OVERVIEW
TABLE 492 INTELERAD MEDICAL SYSTEMS INCORPORATED: SOLUTIONS OFFERED
TABLE 493 INTELERAD MEDICAL SYSTEMS INCORPORATED: DEALS, DECEMBER 2020 NOVEMBER 2023
TABLE 494 INTELERAD MEDICAL SYSTEMS INCORPORATED: OTHER DEVELOPMENTS, JULY 2021 NOVEMBER 2022
  15.1.9 PAXERAHEALTH
TABLE 495 PAXERAHEALTH: BUSINESS OVERVIEW
TABLE 496 PAXERAHEALTH: SOLUTIONS OFFERED
  15.1.10 NOVARAD CORPORATION
TABLE 497 NOVARAD CORPORATION: BUSINESS OVERVIEW
TABLE 498 NOVARAD CORPORATION: SOLUTIONS OFFERED
  15.1.11 HYLAND SOFTWARE, INC.
TABLE 499 HYLAND SOFTWARE, INC.: BUSINESS OVERVIEW
TABLE 500 HYLAND SOFTWARE, INC.: SOLUTIONS OFFERED
TABLE 501 HYLAND SOFTWARE, INC.: PRODUCTS LAUNCHES & UPGRADES, DECEMBER 2020
TABLE 502 HYLAND SOFTWARE, INC.:DEALS, SEPTEMBER 2021 FEBRUARY 2024
  15.1.12 SIEMENS HEALTHCARE LIMITED
TABLE 503 SIEMENS HEALTHCARE LIMITED: BUSINESS OVERVIEW
FIGURE 47 SIEMENS HEALTHCARE LIMITED: COMPANY SNAPSHOT
TABLE 504 SIEMENS HEALTHCARE LIMITED: SOLUTIONS OFFERED
  15.1.13 BRIDGEHEAD SOFTWARE LTD.
TABLE 505 BRIDGEHEAD SOFTWARE LTD.: BUSINESS OVERVIEW
TABLE 506 BRIDGEHEAD SOFTWARE LTD.: SOLUTIONS OFFERED
TABLE 507 BRIDGEHEAD SOFTWARE LTD.: PRODUCTS LAUNCHES & UPGRADES, MAY 2020
TABLE 508 BRIDGEHEAD SOFTWARE LTD.: DEALS, SEPTEMBER 2022
  15.1.14 CANOPY PARTNERS
TABLE 509 CANOPY PARTNERS: BUSINESS OVERVIEW
TABLE 510 CANOPY PARTNERS: SOLUTIONS OFFERED
  15.1.15 CRELIOHEALTH INC.
TABLE 511 CRELIOHEALTH INC.: BUSINESS OVERVIEW
TABLE 512 CRELIOHEALTH INC.: SOLUTIONS OFFERED
  15.1.16 ASPYRA, LLC
TABLE 513 ASPYRA, LLC: BUSINESS OVERVIEW
TABLE 514 ASPYRA, LLC: SOLUTIONS OFFERED
  15.1.17 POSTDICOM
TABLE 515 POSTDICOM: BUSINESS OVERVIEW
TABLE 516 POSTDICOM: SOLUTIONS OFFERED
  15.1.18 MEDICASOFT
TABLE 517 MEDICASOFT: BUSINESS OVERVIEW
TABLE 518 MEDICASOFT: SOLUTIONS OFFERED
  15.1.19 ESAOTE SPA
TABLE 519 ESAOTE SPA.: BUSINESS OVERVIEW
TABLE 520 ESAOTE SPA.: SOLUTIONS OFFERED
  15.1.20 VISUS HEALTH IT GMBH
TABLE 521 VISUS HEALTH IT GMBH: BUSINESS OVERVIEW
TABLE 522 VISUS HEALTH IT GMBH: SOLUTIONS OFFERED
15.2 OTHER PLAYERS
  15.2.1 ADVAHEALTH SOLUTIONS
  15.2.2 SOFTTEAM SOLUTIONS PVT. LTD.
  15.2.3 ARO SYSTEMS
  15.2.4 CENTRAL DATA NETWORKS
  15.2.5 ONEPACS
  15.2.6 DEDALUS S.P.A.

16 APPENDIX

16.1 DISCUSSION GUIDE
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL
16.3 CUSTOMIZATION OPTIONS
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS

About

By bringing desired changes in the clinical workflow and by improving the unification and accessibility of data, VNAs have the capability to provide enhanced patient care. VNAs provide timely access to patient data at the point-of-care. They also offer early access to professional help for patients, they help with faster decision making, and they bring about transparency. Another factor that is driving the need for patient-centric systems is rising patient awareness. The increased awareness of patients with regards to healthcare has greatly helped them to make decisions, especially in the management and treatment of chronic conditions. If the patient has access to his/her personal health information that is shared across public and private clinical organizations, it could enable healthcare providers and patients to collaborate and make informed decisions.

Many EHR systems that are marketed today are featured as "patient portals" that give individuals immediate access to their own lab results, X-ray reports, list of medications, and other information. Similar strategies can be applied to VNAs that would allow patients to communicate securely via e-mail with their physicians and other medical personnel. Thus, installation of VNAs that are developed with the idea of delivering high-quality patient care is poised to increase amongst organizations.

The multi-department VNA segment accounts for the largest share—XX%—of the global VNA market in 2013. This segment is expected to reach $XX million by 2018 at a CAGR of XX% for the same period. Cross-departmental interoperability is seen as the first step to achieving communication within a hospital setting, a factor that explains the largest share and highest CAGR of this segment. The segment is closely followed by departmental VNAs contributing XX% to the market. This procurement model is generally adopted in radiology departments with the view to test a VNA for their department so as to take a further decision of scaling up to a multi-departmental level. A VNA at a multi-site level allows VNA adoption across various hospital enterprises, the trend for which is growing at a rapid pace.

North America commands the largest share—XX%—of the global VNA market at an estimated $XX million in 2013. It is expected to reach $XX million by 2018, at a CAGR of XX% from 2013 to 2018. This growth in the North American market is because of the mandates imposed by the federal government for image enablement of EHRs via Meaningful Use of the HITECH (Healthcare Information Technology for Economical and Clinical Health) Act. The rising imaging volume in the U.S.—owing to the aging population and subsequent demand for diagnostic imaging—is another major reason for its large share.

Europe, on the other hand, has the second-highest share in the VNA market and is the fastest growing region for VNA adoption. The healthcare structure in European countries like U.K., Germany, and France encourages VNA deployment on a multi-site level rather than on a departmental level. Deployment of VNAs on a large scale is expected to bring higher revenues to the European market, thus substantiating the higher growth. Moreover, the European market is more advanced than the U.S. market in terms of standards followed. The European market has begun to adopt the XDS-based VNA while the U.S. market, on the other hand, still lags behind technologically, with the traditional DICOM standard-based VNA still accounting for the largest share in the U.S.